← All companies
About this company
🚀 Exciting News! Introducing TransHeps, a cutting-edge spin-off from the University of Zurich, specializing in groundbreaking laboratory services and advisory expertise for Drug-Induced Liver Injury (DILI) in clinical trials. 🌐 Our Vision: Improve safety during drug therapy by focusing on patient-specific DILI, a rare but potentially life-threatening side effect. 🔍 Our Mission: Make MetaHeps assay a breakthrough tool for DILI causality assessment in clinical studies, serving global pharma developers and regulators. 🛠️ Products & Services: 1. Expert Advisory Services & Consulting around DILI, 2. Exclusive provider of the MetaHeps assay, 3. Tailormade mechanistic in-vitro studies to investigate DILI. 🌟 Differentiation: MetaHeps DILI causality assessment in clinical studies is unrivaled! We are the only industrial service provider of the MetaHeps assay. 👩🔬 Our Team: Seasoned scientists with proven expertise in clinical and experimental hepatology, ensuring top-tier quality standards. 📣 Join us in revolutionizing drug therapy safety! Learn more: https://transheps.com/